Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock $0.001 par value per share
-
Shares outstanding
-
77.8M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
35M
-
Shares change
-
+18.3M
-
Total reported value, excl. options
-
$466M
-
Value change
-
+$255M
-
Put/Call ratio
-
1.21
-
Number of buys
-
43
-
Number of sells
-
-9
-
Price
-
$13.32
Significant Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q1 2024
61 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share as of Q1 2024.
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35M shares
of 77.8M outstanding shares and own 44.96% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.91M shares), RA CAPITAL MANAGEMENT, L.P. (4.33M shares), Bain Capital Life Sciences Investors, LLC (4.03M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.54M shares), Artal Group S.A. (2.5M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.26M shares), JANUS HENDERSON GROUP PLC (1.81M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1.33M shares), VANGUARD GROUP INC (1.24M shares), and Vestal Point Capital, LP (1.04M shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.